Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Instruments & Supplies

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.

Revenue projections:

Revenue projections for SOLV
Revenue projections for SOLV

SOLV is projected to experience a revenue decline compared to last year, a development that often leads to investor caution. The drop could negatively impact the company's bottom line, as lower revenues typically signal reduced profitability, prompting more conservative investment strategies.

Financial Ratios:

currentRatio 1.231000
forwardPE 9.718539
debtToEquity 103.941000
earningsGrowth 1.008000
revenueGrowth -0.037000
grossMargins 0.535740
operatingMargins 0.070070
trailingEps 8.880000
forwardEps 7.028320

SOLV's current ratio of 1.231 shows that the company has ample resources to service its short-term debt. This indicates a solid financial position, as SOLV can rely on its cash reserves and current assets to cover its immediate liabilities without strain.
SOLV's elevated debt-to-equity ratio shows that the company is relying heavily on debt to fund its activities. This high leverage can amplify returns but also heightens financial risks if cash flow becomes constrained.
SOLV's forward EPS is less than its trailing EPS, signaling that the company's profitability is expected to shrink. This points to a potential downturn in earnings compared to last year.

Price projections:

Price projections for SOLV
Price projections for SOLV

SOLV's price has consistently been situated near the lower end of expected values. This ongoing trend may reflect investor skepticism about the company's growth potential and overall performance.

Insider Transactions:

Insider Transactions for SOLV
Insider Transactions for SOLV


1 sell transactions of SOLV were recorded, with market price hovering near 71.41999816894531.SOLV saw 1 transactions to buy shares, with a market price of 67.5999984741211.More buys than sells have been occurring around the current price levels of SOLV, potentially signaling investor optimism. This buying trend might be interpreted as a sign of a favorable outlook for the stock's future performance.

Recommendation changes over time:

Recommendations trend for SOLV
Recommendations trend for SOLV


Analysts have shown a buy bias for SOLV, marking it as a favorable investment option. This could inspire investors to see SOLV as a strong place to park their money, given the positive outlook and growth potential associated with the stock in recent evaluations.